{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:57:07Z","timestamp":1770487027182,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["400894\/2014-9"],"award-info":[{"award-number":["400894\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.05.043","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T09:22:50Z","timestamp":1558689770000},"page":"3660-3667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis"],"prefix":"10.1016","volume":"37","author":[{"given":"Izabella P.S.","family":"Bezerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz L.S.","family":"Costa-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Antonio Miranda","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert Leonel","family":"de Matos Guedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3791-8996","authenticated-orcid":false,"given":"Bartira","family":"Rossi-Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.043_b0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.05.043_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.043_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.043_b0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14760584.2018.1459191","article-title":"Vaccine candidates against leishmania under current research","volume":"17","author":"Iborra","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.043_b0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0030","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00108-17","article-title":"Not all antigens are created equally: progress, challenges, and lessons associated with developing a vaccine for leishmaniasis","volume":"24","author":"Duthie","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.274.5286.421","article-title":"Resistance to Leishmania major induced by tolerance to a single antigen","volume":"274","author":"Julia","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.05.043_b0040","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","article-title":"The mucosal immune system for vaccine development","volume":"32","author":"Lamichhane","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.043_b0045","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.vaccine.2006.05.093","article-title":"Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan","volume":"25","author":"Pinheiro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.043_b0050","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/1756-3305-7-448","article-title":"Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB\/c mice against infection","volume":"7","author":"de Matos","year":"2014","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2019.05.043_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.72.8.4521-4527.2004","article-title":"Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK","author":"Pinto","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.043_b0060","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.vaccine.2006.11.060","article-title":"Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice","volume":"25","author":"de Gomes","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.043_b0065","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1017\/S0031182011001417","article-title":"Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi","volume":"138","author":"De Oliveira Gomes","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2019.05.043_b0070","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1017\/S0031182012000868","article-title":"Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis","volume":"139","author":"De Oliveira Gomes","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2019.05.043_b0075","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1590\/S0100-879X2005000700001","article-title":"What about Th1\/Th2 in cutaneous leishmaniasis vaccine discovery?","volume":"38","author":"Campos-Neto","year":"2005","journal-title":"Brazilian J Med Biol Res = Rev Bras Pesqui Medicas e Biol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0080","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.micinf.2005.04.016","article-title":"TGF-\u03b2-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens","volume":"7","author":"Pinheiro","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.05.043_b0085","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.vaccine.2018.03.020","article-title":"Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis","volume":"36","author":"Pereira Silva Bezerra","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.043_b0090","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.163.8.4481","article-title":"Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis","volume":"163","author":"Kenney","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"V\u00e9lez","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.05.043_b0100","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/S0264-410X(03)00427-4","article-title":"Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB\/c and C57BL\/6 mice against cutaneous leishmaniasis","volume":"21","author":"Pinto","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.043_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003439","article-title":"Intranasal Vaccination with Leishmanial Antigens Protects Golden Hamsters (Mesocricetus auratus) Against Leishmania (Viannia) braziliensis Infection","author":"Da Silva-Couto","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.043_b0110","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1017\/S0031182015001250","article-title":"Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB\/c mice challenged with Leishmania (infantum) chagasi","volume":"142","author":"Leal","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2019.05.043_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-016-1822-9","article-title":"Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl\/6 mice","author":"Pratti","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2019.05.043_b0120","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103 + DCs induces Foxp3 + regulatory T cells via a TGF-\u03b2\u2013 and retinoic acid\u2013dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.05.043_b0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4049\/jimmunol.1300193","article-title":"Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance","volume":"191","author":"Khare","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086554","article-title":"Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A","volume":"9","author":"Rudraraju","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.05.043_b0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.it.2016.12.006","article-title":"Retinoic acid and immune homeostasis: a balancing act","volume":"38","author":"Erkelens","year":"2017","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.043_b0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2172-14-28","article-title":"All-trans retinoic acid attenuates airway inflammation by inhibiting Th2 and Th17 response in experimental allergic asthma","volume":"14","author":"Wu","year":"2013","journal-title":"BMC Immunology."},{"key":"10.1016\/j.vaccine.2019.05.043_b0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000437326","article-title":"The effects of all-trans retinoic acid on the induction of oral tolerance in a murine model of bronchial asthma","volume":"167","author":"Sakamoto","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2009.07.025","article-title":"Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles","volume":"381","author":"Castro","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2019.05.043_b0155","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/AAC.43.7.1776","article-title":"Improvement of in vitro and in vivo antileishmanial activities of 2\u2019, 6\u2019-dihydroxy-4\u2019-methoxychalcone by entrapment in poly(D, L-lactide) nanoparticles","volume":"43","author":"Torres-Santos","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2019.05.043_b0160","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/1523-1747.ep12470632","article-title":"Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin","volume":"96","author":"Fisher","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0165","first-page":"265","article-title":"Retinoic acid promotes mucosal and systemic immune responses after mucosal priming and systemic boosting in mice","volume":"6","author":"Cirelli","year":"2015","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.vaccine.2019.05.043_b0170","unstructured":"Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL - Full Text View - ClinicalTrials.gov n.d. <https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03574701> (accessed February 5, 2019)."},{"key":"10.1016\/j.vaccine.2019.05.043_b0175","doi-asserted-by":"crossref","unstructured":"Marzochi KB, Marzochi MA, Silva AF, Grativol N, Duarte R, Confort EM, et al. Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil. Mem Inst Oswaldo Cruz n.d.;93:205\u201312.","DOI":"10.1590\/S0074-02761998000200014"},{"key":"10.1016\/j.vaccine.2019.05.043_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7068287","article-title":"Differential recruitment of dendritic cells subsets to lymph nodes correlates with a protective or permissive T-cell response during leishmania (viannia) braziliensis or leishmania (leishmania) amazonensis infection","volume":"2016","author":"Carvalho","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.vaccine.2019.05.043_b0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0074-02762007000100013","article-title":"Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl\/6 mice","volume":"102","author":"Pinheiro","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2019.05.043_b0190","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1137971","article-title":"Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation","volume":"316","author":"Burgdorf","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.05.043_b0195","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.4049\/jimmunol.174.11.7147","article-title":"CD4 + CD25 + regulatory T cells restrain pathogenic responses during leishmania amazonensis infection","volume":"174","author":"Ji","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"issue":"314","key":"10.1016\/j.vaccine.2019.05.043_b0205","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1132742","article-title":"Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells","volume":")","author":"Mora","year":"2006","journal-title":"Science (80-"},{"key":"10.1016\/j.vaccine.2019.05.043_b0210","doi-asserted-by":"crossref","first-page":"20140145","DOI":"10.1098\/rstb.2014.0145","article-title":"Potential for use of retinoic acid as an oral vaccine adjuvant","volume":"370","author":"Mwanza-Lisulo","year":"2015","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"10.1016\/j.vaccine.2019.05.043_b0215","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI44262","article-title":"Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice","volume":"121","author":"Hammerschmidt","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.05.043_b0220","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1128\/JVI.00781-11","article-title":"Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge","volume":"85","author":"Tan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.05.043_b0225","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1074-7613(00)80342-8","article-title":"IL-4 rapidly produced by V\u03b24 V\u03b18 CD4 T cells instructs Th2 development and susceptibility to leishmania major in BALB\/c mice","volume":"6","author":"Launois","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2019.05.043_b0230","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<424::AID-IMMU424>3.0.CO;2-U","article-title":"Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate","volume":"28","author":"McSorley","year":"1998","journal-title":"Eur J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930667X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930667X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:48Z","timestamp":1759401168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1930667X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":46,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X1930667X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}